000 01208 a2200361 4500
005 20250511150427.0
264 0 _c19790425
008 197904s 0 0 eng d
022 _a0014-2999
024 7 _a10.1016/0014-2999(78)90275-3
_2doi
040 _aNLM
_beng
_cNLM
100 1 _aLahti, R A
245 0 0 _aInhibition of 3H-spiroperidol binding by an endogenous material from brain.
_h[electronic resource]
260 _bEuropean journal of pharmacology
_cDec 1978
300 _a117-8 p.
_bdigital
500 _aPublication Type: Journal Article
650 0 4 _aAnimals
650 0 4 _aBinding Sites
_xdrug effects
650 0 4 _aBinding, Competitive
650 0 4 _aBrain
_xphysiology
650 0 4 _aButyrophenones
_xmetabolism
650 0 4 _aCattle
650 0 4 _aIn Vitro Techniques
650 0 4 _aNaloxone
_xmetabolism
650 0 4 _aRats
650 0 4 _aReceptors, Dopamine
_xmetabolism
650 0 4 _aSpiperone
_xmetabolism
650 0 4 _aTissue Extracts
_xmetabolism
700 1 _aGay, D D
700 1 _aBarsuhn, C
773 0 _tEuropean journal of pharmacology
_gvol. 53
_gno. 1
_gp. 117-8
856 4 0 _uhttps://doi.org/10.1016/0014-2999(78)90275-3
_zAvailable from publisher's website
999 _c758698
_d758698